Bridgewater Advisors’s DexCom DXCM Stock Holding History

Bridgewater Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$721K	Sell	12,321 -39	-0.3%	-$2.72K	0.04%	184
2025 Q4	$890K	Sell	12,360 -10	-0.1%	-$647	0.06%	153
2025 Q3	$717K	Sell	12,370 -215	-2%	-$17K	0.05%	182
2025 Q2	$1.12M	Sell	12,585 -51	-0.4%	-$4K	0.09%	123
2025 Q1	$901K	Sell	12,636 -381	-3%	-$31.1K	0.08%	130
2024 Q4	$1.03M	Buy	13,017 +433	+3%	+$32.1K	0.11%	81
2024 Q3	$909K	Sell	12,584 -587	-4%	-$48.2K	0.1%	94
2024 Q2	$1.42M	Buy	+13,171	New	+$1.67M	0.18%	72
2014 Q2	$242K	Hold	24,432	–	–	0.2%	78
2014 Q1	$253K	Hold	24,432	–	–	0.25%	71
2013 Q4	$216K	Buy	+24,432	New	+$193K	0.22%	73

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bridgewater Advisors's DXCM Position: Q1 2026 in Review

Bridgewater Advisors reduced its DexCom (DXCM) stake by 0.32% in Q1 2026, selling an estimated $2.72K and leaving 12,321 shares worth $721K. The position accounts for 0.04% of the portfolio, ranked #184.

Bridgewater Advisors first reported a position in DXCM in Q4 2013 and has held it in 11 quarters since. The position peaked at $1.42M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Bridgewater Advisors held 12,321 shares of DexCom worth $721K as of Q1 2026.
Bridgewater Advisors sold 39 DexCom shares in Q1 2026, an estimated $2.72K.
DexCom made up 0.04% of Bridgewater Advisors's portfolio in Q1 2026, its #184 holding.
Bridgewater Advisors first reported a position in DexCom in Q4 2013 and has held it in 11 quarters since.
Bridgewater Advisors's DexCom position peaked at $1.42M in Q2 2024.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.